On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...